Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial.
Eur J Cancer
; 154: 35-45, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-34243076
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Germ-Line Mutation
/
Genes, BRCA1
/
Genes, BRCA2
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Cancer
Year:
2021
Type:
Article